NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Business Update



Dermatology-focused company announces voting results from annual meeting



January 13th, 2005

Senetek PLC (SNTKY), a healthcare technologies company focused on developing anti-aging products, announced that shareholders approved by votes of approximately 99% all 4 resolutions the company put to the shareholders at the Annual General Meeting of Shareholders.

Senetek CEO Frank J. Massino also announced that Andreas Tobler and Uwe Thieme have been re-elected to the board of directors.

Senetek is a life sciences-driven product development and licensing company focused on dermatological and skin care products primarily addressing photo damage and age-related skin conditions.

Senetek's patented compound Kinetin is a naturally...


Source: Women's Health Weekly (2005-01-13)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login